Efficacy of Ilavangathy chooranam in the management of Perumbadu (Dysfunctional Uterine Bleeding)

Therapeutic efficacy of Ilavangathy chooranam in the management of Perumpadu (Dysfunctional Uterine Bleeding)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049623

Enrollment

Registered

2023-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Ilavangathy chooranam: Dosage:6g twice a day with Hot Water Route of administration: oral Duration:20 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients having regular menstrual cycle Patients having any one of the following clinical symptoms Excessive menstrual bleeding Prolonged menstrual bleeding ( >7 days) Blood clots seen in the mensus Patients with PBAC score of more than 100 points in the previous menstrual cycle Patient willing to do USG Pelvis. Patient willing to participate in trial and signing in consent form.

Exclusion criteria

Exclusion criteria: Present Pregnancy and lactation Fibroid uterus Endometriosis Adenomyosis Endometrial polyp Carcinoma Trauma

Design outcomes

Primary

Measure	Time frame
Outcome will be assessed using PBAC scoreTimepoint: 2 MONTHS - SCREENING 2 MONTHS - PATIENT ENROLLMENT 2 MONTHS - OUTCOME ASSESSMENT	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026